Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.82 | - |
NAV | ₹509.16 | - |
Fund Started | 10 May 2004 | - |
Fund Size | ₹8458.68 Cr | - |
Exit Load | Exit load of 1% if redeemed within 1 month. | - |
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.82
-
NAV
₹509.16
-
Fund Started
10 May 2004
-
Fund Size
₹8458.68 Cr
-
Exit Load
Exit load of 1% if redeemed within 1 month.
-
1 Year | -1.25% | - |
3 Year | 21.53% | - |
5 Year | 15.01% | - |
1 Year
-1.25%
-
3 Year
21.53%
-
5 Year
15.01%
-
Equity | 99.47% | - |
Cash | 0.53% | - |
Equity
99.47%
-
Cash
0.53%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.55% |
Lupin Ltd. | 7.59% |
Divi's Laboratories Ltd. | 6.90% |
Cipla Ltd. | 6.33% |
Dr. Reddy's Laboratories Ltd. | 5.83% |
Apollo Hospitals Enterprise Ltd. | 5.63% |
Medplus Health Services Ltd. | 3.47% |
Vijaya Diagnostic Centre Ltd. | 3.41% |
Ajanta Pharma Ltd. | 2.90% |
Glaxosmithkline Pharmaceuticals Ltd. | 2.77% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | - |
Launch Date | 10 May 2004 | - |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
-
Launch Date
10 May 2004
-